<DOC>
	<DOCNO>NCT00315146</DOCNO>
	<brief_summary>The purpose pilot study compare two strategy intend improve health overweight old adult improve body composition . One strategy , resistance training , design preserve skeletal muscle mass . The strategy , use PPAR-γ agonist , design enhance loss fat visceral skeletal depot . These strategy use conjunction hypocaloric diet compare hypocaloric diet alone determine either strategy superior reduce visceral fat preserve muscle mass .</brief_summary>
	<brief_title>Optimizing Body Composition Function Older Adults</brief_title>
	<detailed_description>In pilot propose recruit 88 older ( 65 - 79 yr ) men ( n=48 ) woman ( n=40 ) risk disability indication weight loss accord NIH guideline . All enrol dietary intervention design generate caloric deficit 500 kcal/day 4 month period . All receive supplemental vitamin D calcium . These participant randomize one 4 group : Group 1 - Hypocaloric diet ( placebo ) Group 2 - Hypocaloric diet resistance training design maximize muscular power ( placebo ) Group 3 - Hypocaloric diet PPAR- γ agonist ( pioglitazone/Actos™ ) Group 4 - Hypocaloric diet resistance training pioglitazone/Actos™ The specific aim pilot : 1 . In men woman , determine whether randomization resistance exercise associate increased retention appendicular non-bone lean mass compare undergoing power training . 2 . In men woman , determine whether randomization pioglitazone group associate increased loss visceral adiposity relative randomization non-pioglitazone group . 3 . Assess feasibility recruitment , assessment intervention strategy 4 . To estimate adherence weight loss , exercise training , drug intervention ; 5 . In population , determine measurement characteristic functional outcome consider primary end-points large study . 6 . To obtain pilot data subset participant determine feasibility , acceptability measurement characteristic muscle sample ( biopsy ) quantify intramyocellular lipid study population .</detailed_description>
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>Weight Stable , Indication weight loss per NIH guideline , Performance short physical performance battery score 310 Diabetes , weight &gt; 136 kg , Medical condition limit exercise participation , Congestive heart failure , abnormal kidney function , high ALT normal , currently involve weight loss exercise program , current smoking , alcohol drug abuse , take antiinflammatory steroid , take protein supplement , take PPARgamma agonist , edema , anemia</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Body Composition</keyword>
	<keyword>Sarcopenia</keyword>
	<keyword>Weight loss trial</keyword>
	<keyword>Intervention study</keyword>
	<keyword>Elderly</keyword>
</DOC>